期刊文献+

HPLC-MS/ESI测定人血浆中米格列醇 被引量:3

Determination of miglitol in human plasma by HPLC-MS/ESI
下载PDF
导出
摘要 目的 建立高效液相色谱 质谱联用测定人血浆中米格列醇浓度的方法 ,并用于健康人体内米格列醇药物动力学研究。方法 采用MACHEREY NAGELCN色谱柱 (4. 6mm× 2 5 0mm ,5 μm) ,柱温 5 0℃ ,以乙腈 甲醇 0 . 0 2 %盐酸水溶液为流动相 ,流速0 . 80mL·min-1;质谱采用电喷雾电离源正源 (ESI+ ) ,定量分析采用选择离子监测 (SIR) ,质荷比为准分子离子峰 ;血浆样品用乙腈沉淀后 ,将乙腈挥干 ,残渣用氯仿 异丙醇提取杂质 ,磷酸液提取药物 ,外标法定量。结果 米格列醇浓度在 32~ 32. 0 0ng·mL-1内线性关系良好 ,相关系数为 0 . 9997,最低检测浓度 5ng·mL-1(S/N =3)。批内、批间RSD符合方法学要求 ,单次服用10 .0mg米格列醇片后药动学参数AUC0~ 12 ,AUC0~∞ ,cmax,tmax,t1/2 分别为 (75 92 . 7± 4 2 0 7 .4 )ng·h·mL-1,(795 7 .6± 4 4 2 5 . 7)ng·h·mL-1,(1883. 9± 912 .3)ng·mL-1,(2 . 4± 0 . 6 )h ,(2 . 5± 0 .9)h。结论 该方法稳定、灵敏度高、操作简单 ,适用于米格列醇血药浓度测定及药动学研究。 OBJECTIVE: To establish a high performance liquid chromatography- electrospray mass spectrometry method for the determination of miglitol in human plasma. To study the pharmacokinetics of miglitol in healthy volunteers. METHODS: The HPLC separation was performed on MACHEREY-NAGEL CN column (4.6 mm × 250 mm,5 μm), the column temperature was at 50°C. The mobile phase consisted of acetonitrile, methanol and 0.02% hydrochllric acid, with a flow-rate of 0.80 mL&middotmin-1. The compound was ionized in the electrospray ionization(ESI+) ion source of the mass spectrometer and detected in the selected ion recording (SIR)mode. The samples were extracted by 0.02 mol&middotL-1 phosphoric acid after deposited by acetonitrile. RESULTS: The limit of detection was 5 ng&middotmL-1 for miglitol. The linear range was 0.032-3.20 μg&middotmL-1 with correlation coefficient of 0.999 7. The RSDs of the intra-day and inter-day validation were less than 15%. The results showed that AUC0-12, AUC 0-∞, cmax, tmax, t1/2 of miglitol were (7 592.7 ± 4 207.4)ng&middoth&middotmL-1, (7 957.6 ± 4 425.7)ng&middoth&middotmL-1, (1 883.9 ± 912.3)ng&middotmL-1, (2.4 ± 0.6)h and (2.5 ± 0.9)h, respectively. CONCLUSION: The method appeared to be accurate, sensitive, simple and is suitable for the determination of miglitol in human plasma and pharmacokinetic study.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第1期51-53,共3页 Chinese Pharmaceutical Journal
关键词 高效液相色谱-质谱 米格列醇 药动学 Acetonitrile Body fluids Correlation methods Deposition Extraction High performance liquid chromatography Ionization Mass spectrometry Pharmacokinetics Phosphoric acid
  • 引文网络
  • 相关文献

参考文献2

  • 1Segal P, Feig PU, Schemthaner G, et al.The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone[ J ]. Diabetes Care, 1997,20,5:687.
  • 2Johnson AB, Taylor R. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type Ⅱ diabetic patients[J]. Diabetes Care, 1996,19(6) :559.

同被引文献10

  • 1黄雅琴,田治科.米格列醇片[J].中国新药杂志,2005,14(5):638-639. 被引量:10
  • 2徐萍,向大雄,朱运贵,王峰,张毕奎,李海菊.米格列醇在人体内的药动学和生物等效性[J].中国医院药学杂志,2005,25(5):409-411. 被引量:3
  • 3LIANG W Q.生物药剂学与药动学[M].Beijin:People' s Medical Press,2003,94-95.
  • 4MIYAKAKI R,HANAI T,SUZUKI J,et al.Study of ion-ion interaction for protein-durg binding using a newly developed guanid-bonded phase in liquid-chromatography[J].J Liq Chromatogr,1998,21:2887-2895.
  • 5WANG H L,ZOU H F,ZHANG Y K.Study of competitive binding of drugs to protein by microdialysis/HPLC[J]. 中国科学B辑,1998,28 (1):72-74.
  • 6TIMOTHY D,VEENSTR.Electrospray ionization mass spectrometry in the study of biomolecular non-covalent interactions[J].Biophy Chem,1999,(79):63-79.
  • 7SHE Y M,JI Y P,HE Y F.Et al.Detection of specific noncovalent protein-fullerenols complexes by matrix-assisted laser desorption ionization mass spectrometry[J].高等学校化学学报,1998,19 (11):1735-1738.
  • 8MCLAFFERTY F W.Tandern mass spectrometry[J].Science,1981,214 (4518):280-287.
  • 9TIMOTHY D,VEENSTRA ANDY J.Tomlinson low temperature aqueous electrospray ionization mass spectrometry of noncovalent complexes[J].J Am Soc Mass Spectrom,1998,9:580-584.
  • 10王红霞,杨松成.蛋白质非共价复合物的电喷雾质谱研究进展[J].药学学报,2001,36(4):315-320. 被引量:17

引证文献3

二级引证文献1

;
使用帮助 返回顶部